Managed Care News and Research

RSS

New HCV therapies cost-effective in specific groups of HCV-infected patients

A study led by Boston Medical Center researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients.

31 Mar 2015

USC Hospitalist Leadership Fellowship Program launched at ApolloMed

Apollo Medical Holdings, Inc., an integrated physician-centric healthcare delivery company, and the Keck School of Medicine of the University of Southern California (USC) Internal Medicine Residency Program today announced the launch of the USC Hospitalist Leadership Fellowship Program at ApolloMed.

30 Mar 2015

Amgen receives FDA priority review designation for Kyprolis to treat relapsed multiple myeloma

Amgen today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) of Kyprolis® (carfilzomib) for Injection for the treatment of patients with relapsed multiple myeloma who have received at least one prior therapy.

30 Mar 2015

AdverseEvents launches RxCost to determine economic impact of prescribing particular drugs

AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.

26 Mar 2015

Qualcomm Life, AMC Health to accelerate transformation of health care delivery for at-risk patients

Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated, and AMC Health, a privately held provider of 'real-time' patient management solutions, today announced a collaborative effort to accelerate the transformation of chronic care and population health management by significantly enhancing connectivity and care coordination for at-risk patients, specifically those with heart failure, hypertension, diabetes, asthma or COPD, in a cost-effective manner.

25 Mar 2015

Implementation of video-based decision aids influences care decisions in urology

After Group Health Cooperative implemented video-based decision aids for men with two common prostate conditions, rates of elective surgery for benign prostatic hyperplasia (BPH) and rates of active treatment for localized prostate cancer declined over six months.

24 Mar 2015

Amgen seeks marketing approval of Repatha (evolocumab) in Japan for treatment of high cholesterol

Amgen today announced that an application seeking marketing approval of Repatha (evolocumab) for the treatment of high cholesterol has been submitted for review to the Ministry of Health, Labour and Welfare in Japan.

21 Mar 2015

Expansion of medical system has led people to feel less healthy over time, study finds

Across much of the Western world, 25 years of expansion of the medical system has actually led to people feeling less healthy over time, a new study has found.

20 Mar 2015

Preventing falls in care homes: an interview with Professor Pip Logan

Older people living in care homes fall three times more frequently than individuals who still live in their own homes. There is often debate over the idea of people going into care homes as a solution to the fact they are falling at home but they can still fall in the care home.

16 Mar 2015

Milliman's healthcare analytic platform achieves NCQA certification for HEDIS 2015 Measures

Milliman, Inc., one of the premier global consulting and actuarial firms, announced today that their healthcare analytic platform, MedInsight, has achieved the National Committee for Quality Assurance certification for Healthcare Effectiveness Data and Information Set 2015 Measures. Since its introduction in 1993, HEDIS has evolved to become the gold standard in managed care performance measurement.

12 Mar 2015

BMC researchers to play key role in examining best treatment for acute low back pain

Boston Medical Center researchers are part of a national clinical trial that will examine how best to treat acute low back pain and potentially prevent it from being chronic. BMC will receive $2.3 million for its role in the five-year study that was recently approved for a $14 million award by the Patient-Centered Outcomes Research Institute.

9 Mar 2015

DePaul University experts available to discuss different health care topics

With the fifth anniversary of the presidential signing of the U.S. Affordable Care Act March 23, faculty experts from DePaul University are available to discuss a range of health care topics including the analysis of health care data, community health, patient experience, communication among health care professionals, interprofessional health care education and the role of nurses and physician assistants.

6 Mar 2015

Medicare Part D, adherence can help save patients with high cholesterol

According to the Centers for Disease Control and Prevention, one in three American adults has high cholesterol. For those struggling with high cholesterol, getting needed prescriptions and adhering to the prescribed treatment regimen is critical.

28 Feb 2015

Insurance coverage expansion in Massachusetts increases knee, hip replacement procedures by 4.7%

Researchers at Boston Medical Center have found that the expansion of insurance coverage in Massachusetts increased the number of elective knee and hip replacement procedures by 4.7 percent, with greater increases among black and Hispanic patients.

27 Feb 2015

New study demonstrates cost-saving, health care quality outcomes of pediatric ACO

A new study published in Pediatrics demonstrates the cost-saving and health care quality outcomes of the pediatric Accountable Care Organization Partners for Kids. Results of this study indicate that Partners for Kids successfully improved the value of pediatric healthcare over time through cost containment, while maintaining quality of care.

18 Feb 2015

Breckenridge files Paragraph IV ANDA litigation with Sanofi for generic version of Jevtana

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for cabazitaxel solution; IV (infusion) in 60 mg/1.5 mL (40 mg/mL) strength, a generic version of Jevtana® by Sanofi.

12 Feb 2015

FDA advisory committees to review Amgen's talimogene laherparepvec for metastatic melanoma treatment

Amgen announced today that the Cellular, Tissue and Gene Therapies Advisory Committee and the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration will jointly review the Company's Biologics License Application (BLA) for talimogene laherparepvec.

11 Feb 2015

Researchers propose changes to improve studies about value of health information technology

Studies about the value of health information technology can be improved by broadening the reviews to include both costs and benefits, and lengthening study periods to capture long-term implications, according to a new RAND Corporation analysis.

11 Feb 2015

Amgen's biosimilar Phase 3 rheumatoid arthritis study meets primary and secondary endpoints

Amgen today announced a Phase 3 study evaluating the efficacy and safety of biosimilar candidate ABP 501 compared with Humira® (adalimumab) in patients with moderate-to-severe rheumatoid arthritis met its primary and key secondary endpoints.

4 Feb 2015

Stark Pediatrics' Asif Younus recognized with Physician Summit Award

Buckeye Health Plan recognized Asif Younus, M. D., of Stark Pediatrics, Inc., in Canton with a Physician Summit Award, the company's highest designation for a health care provider. Summit Awards are given each year to primary care physicians and obstetricians for providing clinical excellence.

30 Jan 2015